Flovent hfa and Xopenex hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flovent hfa (fluticasone propionate) and Xopenex hfa (levalbuterol tartrate). Common drug interactions include bacterial infection among females and dysgeusia among males.

The phase IV clinical study analyzes what interactions people have when they take Flovent hfa and Xopenex hfa. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Flovent hfa?

Flovent hfa has active ingredients of fluticasone propionate. It is often used in asthma. eHealthMe is studying from 7,457 Flovent hfa users. Check the latest studies of Flovent hfa.

What is Xopenex hfa?

Xopenex hfa has active ingredients of levalbuterol tartrate. It is often used in asthma. eHealthMe is studying from 2,529 Xopenex hfa users. Check the latest studies of Xopenex hfa.

On Jul, 15, 2026

68 people who take Flovent hfa and Xopenex hfa together, and have interactions are studied.

Flovent hfa and Xopenex hfa drug interactions.

What are the common drug interactions of Flovent Hfa and Xopenex Hfa, by gender? *:

female:

Bacterial infection
Blood magnesium increased
Cellulitis (infection under the skin)
Contusion (a type of hematoma of tissue in which capillaries)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Drug hypersensitivity
Ear pain
Frequent bowel movements
Herpes zoster

male:

Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
Leukocytosis (increased white blood cells)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pneumonia
Anxiety
Coma (state of unconsciousness lasting more than six hours)
Death
Fall

What are the common drug interactions of Flovent Hfa and Xopenex Hfa, by age (0-1 to 60+)? *:

0-1:

Respiratory syncytial virus test positive

2-9:

Aphasia (damage to the parts of the brain that control language)
Confusional state
Granulocytopenia (lack of granulocyte)
Neutrophil percentage decreased

10-19:

Abnormal behaviour
Cardiac failure
Crying
Depression
Fluid overload (too much fluid in the blood)
Hospitalisation
Malaise (a feeling of general discomfort or uneasiness)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Oedema peripheral (superficial swelling)
Oropharyngeal pain

20-29:

n/a

30-39:

Back pain
Cataplexy (loss of muscle tone accompanied by full conscious awareness)
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Cystatin c increased
Cystic fibrosis (disease of the secretary glands)
Dark circles under eyes
Death
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Drug ineffective
Dry eye (lack of adequate tears)

40-49:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiovascular disorder (heart diseases)
Dyspnoea (difficult or laboured respiration)
Ear infection

50-59:

Immunodeficiency
Influenza
Insomnia (sleeplessness)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
Nausea (feeling of having an urge to vomit)
Pain
Palpitations (feelings or sensations that your heart is pounding or racing)
Periorbital cellulitis (inflammation and infection of the eyelid and the skin surrounding the eye)
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

60+:

Dyspnoea (difficult or laboured respiration)
Vocal cord disorder
Glycosylated haemoglobin increased
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
Leukocytosis (increased white blood cells)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Muscle spasms (muscle contraction)
Urinary tract infection
Asthenia (weakness)
Coma (state of unconsciousness lasting more than six hours)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 17.65%
Immunodeficiency Common Variable: 10 people, 14.71%
Immunodeficiency: 10 people, 14.71%
Multiple Myeloma (cancer of the plasma cells): 4 people, 5.88%
Dyspnea (difficult or laboured breathing): 4 people, 5.88%
Diabetes: 4 people, 5.88%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Flovent hfa and Xopenex hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously